ESMC Stock Chart & Stats
$0.17
<$0.01(7.17%)
At close: 4:00 PM EST
$0.17
<$0.01(7.17%)
Day’s Range― - ―
52-Week Range$0.10 - $0.42
Previous CloseN/A
Volume10.00K
Average Volume (3M)30.86K
Market Cap
$1.39M
Enterprise Value-$3.34B
Total Cash (Recent Filing)$3.34B
Total Debt (Recent Filing)$1.01M
Price to Earnings (P/E)1.8
Beta1.78
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.11
Shares Outstanding7,415,329
10 Day Avg. Volume10,422
30 Day Avg. Volume30,865
Financial Highlights & Ratios
PEG Ratio-0.74
Price to Book (P/B)1.25
Price to Sales (P/S)0.20
P/FCF Ratio6.31
Enterprise Value/Market Cap-2.40K
Enterprise Value/Revenue-291.83
Enterprise Value/Gross Profit-703.54
Enterprise Value/Ebitda3.71K
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Escalon Medical News
ESMC FAQ
What was Escalon Medical’s price range in the past 12 months?
Escalon Medical lowest stock price was $0.10 and its highest was $0.42 in the past 12 months.
What is Escalon Medical’s market cap?
Escalon Medical’s market cap is $1.39M.
When is Escalon Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Escalon Medical’s earnings last quarter?
Currently, no data Available
Is Escalon Medical overvalued?
According to Wall Street analysts Escalon Medical’s price is currently Overvalued.
Does Escalon Medical pay dividends?
Escalon Medical does not currently pay dividends.
What is Escalon Medical’s EPS estimate?
Escalon Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Escalon Medical have?
Escalon Medical has 7,415,329 shares outstanding.
What happened to Escalon Medical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Escalon Medical?
Currently, no hedge funds are holding shares in ESMC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Escalon Medical
Escalon Medical Corp. specializes in the field of ophthalmology, engaging in the development, manufacturing, promotion, and distribution of both medical devices and pharmaceutical products. Its operations span the United States and international markets. The company's product line includes a variety of diagnostic instruments for eye care. For instance, the A-Scan is designed to provide insights into the internal anatomy of the eye, while the B-Scan assists physicians in diagnosing conditions where the eye's internal media is obscured or cloudy. They also offer the UBM, a high-frequency, high-resolution ultrasound device that delivers detailed imaging of the anterior segment of the eye, alongside the Pachymeter, which accurately measures corneal thickness. Beyond diagnostic tools, Escalon supplies intraocular gas products such as C3F8 and SF6, vital for vitreoretinal surgeons who utilize them as a temporary support during detached retina surgeries. To complement this, the firm produces and distributes a patented disposable universal gas kit, ensuring the efficient delivery of these gases from the canister to the patient. Furthermore, Escalon provides disposable surgical packs tailored for vitreoretinal procedures and offers the AXIS Image management system. This web-based platform enables the seamless organization and viewing of medical images from diverse devices, manufacturers, and locations. Escalon Medical Corp. distributes its products to medical institutions through a combination of independent sales representatives, an extensive network of distributors, and its dedicated internal sales personnel. Established in 1987, the company maintains its corporate headquarters in Wayne, Pennsylvania.
Technical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
2.44% Other Institutional Investors
97.56% Public Companies and
Individual Investors
